Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

Historical Holders from Q1 2020 to Q3 2025

Symbol
ANVS on NYSE
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
19.6M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2.02M
Holdings value
$4.19M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
42
Number of buys
15
Number of sells
-13
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVI Investments, Inc. 4.9% -4% $1.47M 1M 0% CVI Investments, Inc. 31 Mar 2025

Institutional Holders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2.02M $4.19M +$428K $2.07 42
2025 Q2 1.81M $3.93M -$326K $2.17 42
2025 Q1 2.09M $3.13M -$507K $1.50 43
2024 Q4 1.58M $7.93M +$1.7M $5.03 40
2024 Q3 1.18M $9.5M +$1.92M $8.06 35
2024 Q2 984K $5.67M -$2.07M $5.76 29
2024 Q1 1.19M $14.2M -$405K $11.90 29
2023 Q4 1.2M $22.5M +$2.42M $18.70 35
2023 Q3 1.11M $10.6M -$1.63M $9.49 28
2023 Q2 1.28M $18.3M +$7.49M $14.29 27
2023 Q1 752K $11.6M +$251K $15.41 22
2022 Q4 736K $9.89M +$231K $13.43 21
2022 Q3 719K $9.85M -$399K $13.70 20
2022 Q2 770K $8.74M -$1.48M $11.33 24
2022 Q1 889K $11.9M -$3.78M $13.35 22
2021 Q4 1.12M $19.6M -$2.6M $17.58 29
2021 Q3 1.14M $36.2M -$24.7M $31.74 36
2021 Q2 1.27M $109M +$39.3M $85.59 56
2021 Q1 834K $23.1M +$2.87M $27.90 29
2020 Q4 760K $5.73M +$93.8K $7.55 12
2020 Q3 316K $1.52M +$388K $4.81 11
2020 Q2 244K $1.06M +$221K $4.35 8
2020 Q1 193K $580K +$580K $3.01 6